NCT00655863 Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes. Status COMPLETED Phase PHASE3
NCT00653185 Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00641732 Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement Status COMPLETED Phase PHASE2
NCT00634036 Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics Status COMPLETED Phase PHASE2
NCT00633477 Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure Status TERMINATED Phase PHASE3
NCT00629876 A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy. Status TERMINATED Phase PHASE1
NCT00627016 A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn Status COMPLETED Phase PHASE3
NCT00622427 Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia Status COMPLETED Phase PHASE4
NCT00611442 Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy Status COMPLETED Phase NA
NCT00598442 Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis Status COMPLETED Phase PHASE3
NCT00598273 Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis Status COMPLETED Phase PHASE3
NCT00597753 Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis Status COMPLETED Phase PHASE3
NCT00597584 Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis Status COMPLETED Phase PHASE3
NCT00595504 Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00593736 Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome Status COMPLETED Phase PHASE2
NCT00591773 Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00591578 Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension Status COMPLETED Phase PHASE3
NCT00591266 Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension Status COMPLETED Phase PHASE3